California Cancer Reporting System Standards, Volume III
CCR ID |
NAACCR ID |
E1430 |
9925 |
This data item has been retired. This page has been retained for historical purposes only and this data item should not be populated in any cases diagnosed 2013 or later or coded under the NAACCR v13 or later coding standards.
Codes the type ofbiological response modifier therapy (immunotherapy) given as part of a subsequent course of treatment.
Tumors, Admissions
2
00 |
None OR Not applicable (e.g., not required for this primary site/histology) OR Unknown information |
01 |
Immunotherapy administered as subsequent therapy. |
Blank |
|
No longer uploaded
None
n/a
IF775 Reason Subsq RX, Subsq RX
IF928 Subsq RX 2ndCrs BRM, Subsq BRM 1 NSC
IF932 Subsq RX, Date of DX, Site, Hist
2011 Data Item Changes, CER Project |
Added for CER requirements. |
May 2013 |
Retired at the conclusion of data collection for the CER project |